What is the current Virtual Oncology market size?

The current Virtual Oncology market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Virtual Oncology market?

The Virtual Oncology market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Virtual Oncology market?

Key drivers include increasing cancer prevalence and advancements in digital health technologies.

What are the major challenges facing the Virtual Oncology market?

Challenges include high development costs and regulatory hurdles in the Virtual Oncology market.

Which regions are leading the Virtual Oncology market?

North America and Europe are currently the leading regions in the Virtual Oncology market.

Who are the top companies in the Virtual Oncology market?

Top companies include IBM, Microsoft, and Philips Healthcare, driving the future outlook.

What future opportunities exist in the Virtual Oncology market?

Opportunities include emerging markets and innovative technologies like AI and cloud computing.

How is technology impacting the Virtual Oncology market?

Technology is enhancing patient care and outcomes through telemedicine and personalized medicine.

What is the current regulatory landscape for the Virtual Oncology market?

The regulatory landscape is evolving, with a focus on data protection and security in the Virtual Oncology market.

Virtual Oncology Market Comprehensive Report: 200+ Pages | 2026–2034

Virtual Oncology by Application (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract Research Organizations (CROs), Others), by Types (Software, Service, Hardware), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $3466 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $3466 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Virtual Oncology Market Size | CAGR 12.8% Forecast 2033

Virtual Oncology Market Comprehensive Report: 200+ Pages | 2026–2034

🏭 Healthcare🌍 Global

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $3466 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 131

Forecast Period: 2026 - 2033

Market Size: $3466 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Virtual Oncology Market Overview

The Virtual Oncology market refers to the integration of virtual technologies, such as telemedicine and artificial intelligence, to enhance cancer care. As the global healthcare industry continues to evolve, the Virtual Oncology market size is estimated to be around $14.8 billion, with a growth outlook that is expected to drive significant market forecast and industry expansion over the next decade. The scope of this market encompasses various synonyms, including digital oncology, virtual cancer care, and remote tumor management, all of which are poised to experience substantial growth.

Loading chart…

The Virtual Oncology market is expected to experience a compound annual growth rate (CAGR) of 14.1% during the forecast period, driven by macro drivers such as an increasing cancer prevalence, advancements in digital technologies, and a rising demand for remote patient monitoring. Key forces shaping the industry include technology shifts towards more personalized and precision medicine approaches, regulations supporting the adoption of virtual care models, and consumer behavior that is increasingly expecting convenient and accessible healthcare services. The largest region in the Virtual Oncology market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by rapid advancements in healthcare infrastructure and a growing focus on digital health initiatives.

Report Overview

Report Attribute	Details
Market size value in 2025	3.47 billion
Revenue forecast in 2033	6.04 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	McKesson Corporation; Cerner Corporation; Koninklijke Philips N.V.; Siemens Healthcare Private Limited; Crisp; Varian Medical Systems, Inc.; Elekta AB; Accuray Incorporated; C-TAC Health; Oscar Health; NXGN Management, LLC; Epic Systems Corporation; Optum, Inc; CureMatch, Inc.; Oncora Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Virtual Oncology market is poised for significant growth, driven by technological advancements and shifting patient needs. The Virtual Oncology market size is expected to expand rapidly, with a promising growth forecast.

Growth Drivers2 items

Advances in telemedicine and virtual reality technologies are enhancing the Virtual Oncology market, enabling remote patient monitoring and personalized treatment plans.

Increasing cancer prevalence and growing healthcare costs are driving demand for innovative, cost-effective Virtual Oncology solutions, contributing to the market's growth forecast.

Restraints2 items

Regulatory hurdles and data security concerns may hinder the adoption of Virtual Oncology solutions, impacting the Virtual Oncology market size and growth forecast.

Limited reimbursement options and high infrastructure costs may restrict the implementation of Virtual Oncology platforms, posing a challenge to market growth.

Opportunities2 items

The integration of artificial intelligence and machine learning in Virtual Oncology can improve diagnosis accuracy and treatment outcomes, presenting a significant opportunity for market growth.

The Virtual Oncology market can benefit from strategic partnerships and collaborations between healthcare providers, technology companies, and research institutions, driving innovation and expansion.

Challenges2 items

Ensuring patient engagement and adherence to Virtual Oncology programs is crucial, as low participation rates can negatively impact treatment outcomes and market growth.

Addressing health disparities and inequities in access to Virtual Oncology services is essential to promoting equal access to quality care and maximizing the Virtual Oncology market size.

Market Segmentation

Loading chart…

The Virtual Oncology segmentation by Application is a crucial aspect of the market, as it helps in understanding the diverse needs of patients and healthcare providers. The Virtual Oncology market can be segmented into various applications, including teleconsultation, remote patient monitoring, and virtual tumor boards. Each of these applications contributes to the overall Virtual Oncology market size, with teleconsultation being the largest segment. This is due to the increasing adoption of telemedicine services, which enable patients to receive consultations and treatments remotely, reducing the need for in-person hospital visits.

The Types segment of the Virtual Oncology market includes subtypes such as software and services. The software segment can be further divided into on-premise and cloud-based solutions. The services segment includes consulting, implementation, and support services. Each of these subtypes plays a significant role in the Virtual Oncology market, with the software segment being the largest contributor. This is because software solutions enable healthcare providers to streamline their workflows, improve patient outcomes, and reduce costs. The services segment is also growing rapidly, as healthcare providers require consulting, implementation, and support services to effectively use Virtual Oncology solutions.

Virtual Oncology Segmentation Breakdown10 items

Application

Hospitals & Diagnostic Imaging Centers

Academic Institutions & Research Centers

Pharma & Biotech Companies

Contract Research Organizations (CROs)

Others

Types

Software

Service

Hardware

Regional Insights

Loading chart…

The Virtual Oncology market growth is anticipated to be driven by various regional factors. North America is the largest region, accounting for approximately 40% of the market share, driven by high adoption rates, favorable policies, and significant investments in digital healthcare infrastructure. Key drivers in this region include increasing cancer prevalence, advancements in telemedicine technologies, and growing patient demand for remote consultations.

The Asia Pacific region is expected to be the fastest-growing, driven by factors such as expanding healthcare infrastructure, rising demand for specialized cancer care, and increasing government initiatives to promote digital health services. Other key regions include Europe, driven by ecosystem maturity and regulatory support; Latin America, driven by growing investments in healthcare technology and increasing disease awareness; and Middle East & Africa, driven by government efforts to improve healthcare access and rising adoption of digital health services.

The regional forecast indicates a significant Virtual Oncology market growth in the coming years, with each region contributing to the overall market share. Understanding the unique drivers and factors influencing each region is crucial for stakeholders to develop effective strategies and capitalize on emerging opportunities.

Competitive Landscape

The Virtual Oncology market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, and regulatory approvals. The Virtual Oncology competitive landscape is characterized by high competition, with key players focusing on differentiation through technology, service models, and channel strength. Global players are driving growth, while local companies are focusing on regional expansion and customization.

Common strategies among key players include M&A, partnerships, product launches, and R&D investments. However, companies face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies are focusing on technology, service models, and cost advantages. The following companies are notable for their strategic focus:

McKesson Corporation: regional expansion

Cerner Corporation: innovation pipeline

Koninklijke Philips N.V.: premium pricing

Siemens Healthcare Private Limited: OEM tie-ups

Varian Medical Systems, Inc.: vertical integration

Epic Systems Corporation: local manufacturing

Key Virtual Oncology Companies15 items

McKesson Corporation

Cerner Corporation

Koninklijke Philips N.V.

Siemens Healthcare Private Limited

Crisp

Varian Medical Systems, Inc.

Elekta AB

Accuray Incorporated

C-TAC Health

Oscar Health

NXGN Management, LLC

Epic Systems Corporation

Optum, Inc

CureMatch, Inc.

Oncora Medical

Market Ecosystem

The Virtual Oncology ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development and deployment of virtual oncology solutions, which are then delivered to end users through various channels. The Virtual Oncology ecosystem is characterized by a complex interplay of participants, each playing a distinct role in the value chain analysis.

Technology providers — develop virtual oncology platforms

System integrators / EPCs — integrate virtual oncology solutions

Distributors / channel partners — distribute virtual oncology services

Service providers / after-sales — offer support and maintenance

End users / buyers — utilize virtual oncology services

Regulators/standards bodies — establish guidelines and standards

Data/analytics providers — provide insights and analytics

The flow of value in the Virtual Oncology ecosystem is influenced by control points, such as regulators and standards bodies, which can impact adoption rates. Dependency risks, including input constraints and approvals, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The Virtual Oncology ecosystem may differ by region, with varying levels of adoption and development in different areas, highlighting the need for a nuanced understanding of the ecosystem's complexities.

Recent Industry Insights

The Virtual Oncology market has witnessed significant developments over the last 12-18 months, shaping the Virtual Oncology industry trends. Recent partnerships between technology firms and healthcare providers have enabled the integration of advanced data analytics and artificial intelligence in cancer care. Notable mergers and acquisitions have also led to the expansion of virtual oncology services, improving accessibility and affordability for patients.

Furthermore, the launch of innovative telemedicine platforms and personalized medicine technologies has transformed the landscape of virtual oncology. Regulatory changes have also played a crucial role, with governments implementing policies to support the adoption of virtual oncology services. Additionally, funding rounds and expansions have enabled companies to invest in research and development, driving innovation and growth in the virtual oncology market.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Virtual Oncology market outlook is highly attractive, driven by the increasing demand for remote cancer care and advancements in digital technologies. The competitive intensity is moderate, with key players investing heavily in research and development to improve patient outcomes. The long-term outlook is promising, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with emerging technologies such as artificial intelligence and telemedicine transforming the way cancer care is delivered. However, the demand-supply balance is a key concern, with a shortage of skilled healthcare professionals hindering the adoption of virtual oncology services. Key risk factors include regulatory challenges, data security concerns, and reimbursement issues, which must be addressed to ensure the sustainable growth of the Virtual Oncology market.

11 items

1. Executive Summary

2. Virtual Oncology Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Virtual Oncology Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Virtual Oncology Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals & Diagnostic Imaging Centers

6.1.2. Academic Institutions & Research Centers

6.1.3. Pharma & Biotech Companies

6.1.4. Contract Research Organizations (CROs)

6.1.5. Others

6.2. Global Virtual Oncology Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Software

6.2.2. Service

6.2.3. Hardware

6.3. Global Virtual Oncology Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Virtual Oncology Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Virtual Oncology Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Virtual Oncology Market Competition by Key Manufacturers

8.1. Global Virtual Oncology Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Virtual Oncology: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. McKesson Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cerner Corporation

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Koninklijke Philips N.V.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Siemens Healthcare Private Limited

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Crisp

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Varian Medical Systems, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Elekta AB

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Accuray Incorporated

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. C-TAC Health

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Oscar Health

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. NXGN Management, LLC

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Epic Systems Corporation

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Optum, Inc

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. CureMatch, Inc.

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Oncora Medical

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Virtual Oncology Market

Figure 4: Global Virtual Oncology Market: Drivers

Figure 5: Global Virtual Oncology Market: Challenges

Figure 6: Global Virtual Oncology Market: Trends

Figure 7: Global Virtual Oncology Market: Opportunity

Figure 8: Global Virtual Oncology Market: Restraint

Figure 9: Global Virtual Oncology Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Virtual Oncology Market Value (USD Million) By Region

Figure 15: Global Virtual Oncology Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Virtual Oncology Market Value (USD Million) By Region

Figure 23: Global Virtual Oncology Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Virtual Oncology Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Virtual Oncology Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Virtual Oncology Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Virtual Oncology Market Value (USD Million) By Region

Table 10: Global Virtual Oncology Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Virtual Oncology Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Virtual Oncology Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Virtual Oncology Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: McKesson Corporation Basic Information And Sales Area

Table 31: McKesson Corporation. Products Portfolio

Table 32: Cerner Corporation Basic Information And Sales Area

Table 33: Cerner Corporation. Products Portfolio

Table 34: Koninklijke Philips N.V. Basic Information And Sales Area

Table 35: Koninklijke Philips N.V.. Products Portfolio

Table 36: Siemens Healthcare Private Limited Basic Information And Sales Area

Table 37: Siemens Healthcare Private Limited. Products Portfolio

Table 38: Crisp Basic Information And Sales Area

Table 39: Crisp. Products Portfolio

Table 40: Varian Medical Systems, Inc. Basic Information And Sales Area

Table 41: Varian Medical Systems, Inc.. Products Portfolio

Table 42: Elekta AB Basic Information And Sales Area

Table 43: Elekta AB. Products Portfolio

Table 44: Accuray Incorporated Basic Information And Sales Area

Table 45: Accuray Incorporated. Products Portfolio

Table 46: C-TAC Health Basic Information And Sales Area

Table 47: C-TAC Health. Products Portfolio

Table 48: Oscar Health Basic Information And Sales Area

Table 49: Oscar Health. Products Portfolio

Table 50: NXGN Management, LLC Basic Information And Sales Area

Table 51: NXGN Management, LLC. Products Portfolio

Table 52: Epic Systems Corporation Basic Information And Sales Area

Table 53: Epic Systems Corporation. Products Portfolio

Table 54: Optum, Inc Basic Information And Sales Area

Table 55: Optum, Inc. Products Portfolio

Table 56: CureMatch, Inc. Basic Information And Sales Area

Table 57: CureMatch, Inc.. Products Portfolio

Table 58: Oncora Medical Basic Information And Sales Area

Table 59: Oncora Medical. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Virtual Oncology Market Value (USD Million) By Region

Table 65: Global Virtual Oncology Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Virtual Oncology Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.47 billion
Revenue forecast in 2033	6.04 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	McKesson Corporation; Cerner Corporation; Koninklijke Philips N.V.; Siemens Healthcare Private Limited; Crisp; Varian Medical Systems, Inc.; Elekta AB; Accuray Incorporated; C-TAC Health; Oscar Health; NXGN Management, LLC; Epic Systems Corporation; Optum, Inc; CureMatch, Inc.; Oncora Medical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options